hero section gradient
17 handpicked stocks

Companies That Give Back

Channel your investments toward companies that make philanthropy a priority. These stocks have been carefully selected by our analysts for their commitment to giving back while building sustainable businesses that could deliver long-term value to investors.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Summary of total market capitalisation and investor takeaways for the provided stock basket.

Key Takeaways for Investors:
  • Large-cap dominance tends to reduce volatility and produce performance closer to broad-market returns.
  • Best employed as a core, long-term holding within a diversified portfolio, not as a speculative trade.
  • Likely to deliver steady, long-term value rather than rapid, short-term gains.
Total Market Cap
  • MSFT: $3.85T

  • CRM: $250.77B

  • GOOGL: $3.03T

  • Other

About This Group of Stocks

1

Our Expert Thinking

Companies that prioritize giving back often build stronger brands and more sustainable business models. These firms demonstrate their values through significant charitable giving and community programs, potentially positioning them for loyal customers and long-term stability.

2

What You Need to Know

This collection spans diverse sectors including technology, healthcare, retail, and consumer goods. Each company has earned recognition for their philanthropic initiatives, from product donations to community development. Their social responsibility may signal good governance and sustainable business practices.

3

Why These Stocks

These companies weren't selected randomly—they've demonstrated consistent commitment to philanthropy through foundations, financial contributions, and volunteering programs. With growing investor interest in ESG factors, these firms may be well-positioned as values-based investing continues to gain momentum.

Why You'll Want to Watch These Stocks

💖

Do Well While Doing Good

These companies aren't just writing checks—they've built giving into their business models. As consumers increasingly support brands that share their values, these firms may have an edge in building customer loyalty.

📈

The ESG Momentum

ESG investing is gaining serious traction. With more investors looking for socially responsible companies, these philanthropic leaders could experience increased demand and potentially attractive valuations.

🔮

Tomorrow's Business Leaders

Companies that focus on community impact often attract and retain top talent while building more resilient business models. Their long-term perspective might translate to sustainable growth that outlasts market cycles.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions